Primary Souter-Strathclyde total elbow prosthesis in XXXX .

@entity1 @entity174 @entity16 @entity281 @entity158 @entity309
BACKGROUND: Total elbow arthroplasty is a well-established treatment for the @entity158 in @entity1 with @entity309 . We present the results of what we believe to be the first prospective study of the Souter-Strathclyde total elbow prosthesis. METHODS: Between June 1982 and December 2000, 204 primary total elbow prostheses were inserted in 166 @entity1 who had @entity309 . No @entity1 was lost to follow-up. The mean duration of follow-up was 6.4 years. All @entity1 were examined preoperatively, at one and two years postoperatively, and at regular intervals thereafter. RESULTS: Six of the 204 elbows had @entity158 at rest at the time of the latest follow-up. Ten @entity1 (ten elbows) without previous @entity16 had development of paresthesias in the distribution of the ulnar nerve postoperatively. @entity1 who had @entity158 at rest or at night and those who had ulnar nerve symptoms preoperatively were found to have a significant chance of having the same complaints postoperatively. @entity158 at rest or at night and a decrease in function during the follow-up period were associated with humeral loosening. Twenty-four elbows had revision of the total elbow prosthesis because of loosening of the humeral component (ten), loosening after @entity174 (six), dislocation (four), @entity281 (two), restricted range of motion (one), or @entity174 of the middle part of the humeral shaft, proximal to the prosthesis (one). One prosthesis was removed because of humeral loosening, and eight were removed because of @entity281 . Another five prostheses were radiographically loose at the time of the latest follow-up. The rate of implant survival, according to the method of Kaplan-Meier, was 77.4% after ten years and 65.2% after eighteen years. CONCLUSIONS: Total elbow replacement is associated with a high complication rate and therefore may be warranted only for seriously disabled @entity1 . Currently, the results associated with the Souter-Strathclyde total elbow prosthesis are comparable with the results associated with other prostheses, but loosening of the humeral component remains a concern. LEVEL OF EVIDENCE: Therapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.
